NASDAQ:COCH

Envoy Medical Q2 2026 Earnings Results & Report

Envoy Medical logo
$6.92 +0.18 (+2.67%)
Closing price 04:00 PM Eastern
Extended Trading
$6.94 +0.03 (+0.36%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envoy Medical beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 10, 2026. The company reported EPS of -$0.70 versus the -$0.80 consensus estimate, while revenue of $51 thousand topped the $50 thousand estimate by $1,000.00.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Envoy Medical EPS Results

Actual EPS
-$0.70
Consensus EPS
-$0.80
Beat/Miss
Beat by +$0.10
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 8 quarters

Envoy Medical Revenue Results

Actual Revenue
$51 thousand
Expected Revenue
$50 thousand
Beat/Miss
Beat by +$1.00 thousand
YoY Revenue Growth
N/A

Envoy Medical Q2 2026 Earnings FAQ

Envoy Medical (NASDAQ:COCH) reported earnings of -$0.70 per share for Q2 2026, beating the consensus estimate of -$0.80. The report was announced on Monday, August 10, 2026.

Envoy Medical reported revenue of $51 thousand for Q2 2026, against a consensus estimate of $50 thousand.

Envoy Medical Earnings Headlines

FY2026 EPS Forecast for Envoy Medical Increased by Analyst
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
HC Wainwright Reaffirms Buy Rating for Envoy Medical (NASDAQ:COCH)
Envoy (COCH) Q3 2026 Earnings Call Transcript
See More Envoy Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Envoy Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Envoy Medical and other key companies, straight to your email.

About Envoy Medical

Envoy Medical (NASDAQ:COCH) is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss.

Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss. Acclaim remains investigational and is not approved for commercial use.

View Envoy Medical Profile